The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis
Open accessAbstract
Extracellular adenosine is a potent immunosuppressor that accumulates during tumor growth. We performed proof-of-concept studies investigating the therapeutic potential and mechanism of action of monoclonal antibody (mAb)-based therapy against CD73, an ecto-enzyme overexpressed on breast-cancer cells that catalyzes the dephosphorylation of adenosine monophosphates into adenosine. We showed that anti-CD73 mAb therapy significantly delayed primary 4T1.2 and E0771 tumor growth in immune-competent mice and significantly inhibited the development of spontaneous 4T1.2 lung metastases. Notably, anti-CD73 mAb therapy was essentially dependent on the induction of adaptive anti-tumor immune responses. Knockdown of CD73 in 4T1.2 tumor cells confirmed the tumor-promoting effects of CD73. In addition to its immunosuppressive effect, CD73 enhanced tumor-cell chemotaxis, suggesting a role for CD73-derived adenosine in tumor metastasis. Accordingly, administration of adenosine-5′-N-ethylcarboxamide to tumor-bearing mice significantly enhanced spontaneous 4T1.2 lung metastasis. Using selective adenosine-receptor antagonists, we showed that activation of A2B adenosine receptors promoted 4T1.2 tumor-cell chemotaxis in vitro and metastasis in vivo. In conclusion, our study identified tumor-derived CD73 as a mechanism of tumor immune escape and tumor metastasis, and it also established the proof of concept that targeted therapy against CD73 can trigger adaptive anti-tumor immunity and inhibit metastasis of breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D., Usheva, A., Erat, A., Chen, J.-F., Enjyoji, K., Linden, J., Oukka, M., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062512 · Cited by 2,470
Self-citationThe Inflammasomes: Guardians of the Body
Martinon, F., Mayor, A., & Tschopp, J. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132715 · Cited by 2,436
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
Haskó, G., Linden, J., Cronstein, B., & Pacher, P. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2638 · Cited by 1,217
A2A adenosine receptor protects tumors from antitumor T cells
Ohta, A., Gorelik, E., Prasad, S. J., Ronchese, F., Lukashev, D., Wong, M. K. K., Huang, X., Caldwell, S., Liu, K., Smith, P., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605251103 · Cited by 1,065
ATP Release Guides Neutrophil Chemotaxis via P2Y2 and A3 Receptors
Chen, Y., Corriden, R., Inoue, Y., Yip, L., Hashiguchi, N., Zinkernagel, A., Nizet, V., Insel, P. A., & Junger, W. G. (2006) · Science · doi:10.1126/science.1132559 · Cited by 858
Molecular Approach to Adenosine Receptors: Receptor-Mediated Mechanisms of Tissue Protection
Linden, J. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.775 · Cited by 685
Synnestvedt, K., Furuta, G. T., Comerford, K. M., Louis, N. A., Karhausen, J., Eltzschig, H. K., Hansen, K. R., Thompson, L. F., & Colgan, S. P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15337 · Cited by 679
Increased Level of Extracellular ATP at Tumor Sites: In Vivo Imaging with Plasma Membrane Luciferase
Pellegatti, P., Raffaghello, L., Bianchi, G., Piccardi, F., Pistoia, V., & Di Virgilio, F. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002599 · Cited by 668
Crucial Role for Ecto-5′-Nucleotidase (CD73) in Vascular Leakage during Hypoxia
Thompson, L. F., Eltzschig, H. K., Ibla, J. C., Van De Wiele, C. J., Resta, R., Morote-Garcia, J. C., & Colgan, S. P. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040915 · Cited by 543
Physiological roles for ecto-5’-nucleotidase (CD73)
Colgan, S. P., Eltzschig, H. K., Eckle, T., & Thompson, L. F. (2006) · Purinergic Signalling · doi:10.1007/s11302-005-5302-5 · Cited by 500
Adenosine receptors in regulation of dendritic cell differentiation and function
Novitskiy, S. V., Ryzhov, S., Zaynagetdinov, R., Goldstein, A. E., Huang, Y., Tikhomirov, O. Y., Blackburn, M. R., Biaggioni, I., Carbone, D. P., Feoktistov, I., et al. (2008) · Blood · doi:10.1182/blood-2008-02-136325 · Cited by 430
Ecto‐enzyme and signaling functions of lymphocyte CD 7 3
Resta, R., Yamashita, Y., & Thompson, L. F. (1998) · Immunological Reviews · doi:10.1111/j.1600-065x.1998.tb01574.x · Cited by 332
Mizumoto, N., Kumamoto, T., Robson, S. C., Sévigny, J., Matsue, H., Enjyoji, K., & Takashima, A. (2002) · Nature Medicine · doi:10.1038/nm0402-358 · Cited by 327
A2B adenosine receptor dampens hypoxia-induced vascular leak
Eckle, T., Faigle, M., Grenz, A., Laucher, S., Thompson, L. F., & Eltzschig, H. K. (2008) · Blood · doi:10.1182/blood-2007-10-117044 · Cited by 302
Madara, J. L., Patapoff, T. W., Gillece-Castro, B., Colgan, S. P., Parkos, C. A., Delp, C., & Mrsny, R. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116462 · Cited by 291
Sitkovsky, M. V., Kjaergaard, J., Lukashev, D., & Ohta, A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0229 · Cited by 253
Hoskin, D., Mader, J., Furlong, S., Conrad, D., & Blay, J. (2008) · International Journal of Oncology · doi:10.3892/ijo.32.3.527 · Cited by 242
Lennon, P. F., Taylor, C. T., Stahl, G. L., & Colgan, S. P. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.8.1433 · Cited by 229
Eckhardt, B. L., Parker, B. S., van Laar, R. K., Restall, C. M., Natoli, A. L., Tavaria, M. D., Stanley, K. L., Sloan, E. K., Moseley, J. M., & Anderson, R. L. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.1.3.1 · Cited by 224
Mills, J. H., Thompson, L. F., Mueller, C., Waickman, A. T., Jalkanen, S., Niemela, J., Airas, L., & Bynoe, M. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711175105 · Cited by 209
Ecto-5′-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells
Wang, L., Zhou, X., Zhou, T., Ma, D., Chen, S., Zhi, X., Yin, L., Shao, Z., Ou, Z., & Zhou, P. (2008) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-007-0292-z · Cited by 196
Human sebaceous tumors harbor inactivating mutations in LEF1
Takeda, H., Lyle, S. R., Lazar, A. J., Zouboulis, C. C., Smyth, I., & Watt, F. M. (2006) · Nature Medicine · doi:10.1038/nm1386 · Cited by 167
Contribution of Adenosine A2B Receptors to Inflammatory Parameters of Experimental Colitis
Frick, J.-S., MacManus, C. F., Scully, M. M., Glover, L. E., Eltzschig, H. K., & Colgan, S. P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801324 · Cited by 157
Zhi, X., Chen, S., Zhou, P., Shao, Z., Wang, L., Ou, Z., & Yin, L. (2007) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9081-y · Cited by 149
Fukuda, K., Sakakura, C., Miyagawa, K., Kuriu, Y., Kin, S., Nakase, Y., Hagiwara, A., Mitsufuji, S., Okazaki, Y., Hayashizaki, Y., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602187 · Cited by 144
The role of ecto-5′-nucleotidase/CD73 in glioma cell line proliferation
Bavaresco, L., Bernardi, A., Braganhol, E., Cappellari, A. R., Rockenbach, L., Farias, P. F., Wink, M. R., Cañedo, A. D., & Battastini, A. M. O. (2008) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9877-3 · Cited by 133
Leth‐Larsen, R., Lund, R. R., Hansen, H. V., Lænkholm, A., Tarin, D., Jensen, O. N., & Ditzel, H. J. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800061-mcp200 · Cited by 129
Goldfinger, L. E., Han, J., Kiosses, W. B., Howe, A. K., & Ginsberg, M. H. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200304031 · Cited by 121
Koeppen, M., Eckle, T. D. L. G., & Eltzschig, H. K. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006784 · Cited by 101
Integrin-mediated Protein Kinase A Activation at the Leading Edge of Migrating Cells
Lim, C. J., Kain, K. H., Tkachenko, E., Goldfinger, L. E., Gutierrez, E., Allen, M. D., Groisman, A., Zhang, J., & Ginsberg, M. H. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-06-0564 · Cited by 98
CD73-Generated Adenosine Restricts Lymphocyte Migration into Draining Lymph Nodes
Takedachi, M., Qu, D., Ebisuno, Y., Oohara, H., Joachims, M. L., McGee, S. T., Maeda, E., McEver, R. P., Tanaka, T. T., Miyasaka, M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.6288 · Cited by 93
Differential ectonucleotidase expression in human bladder cancer cell lines
Stella, J., Bavaresco, L., Braganhol, E., Rockenbach, L., Farias, P. F., Wink, M. R., Azambuja, A. A., Barrios, C. H., Morrone, F. B., & Battastini, A. M. O. (2009) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2009.01.035 · Cited by 90
Inhibition of Siah ubiquitin ligase function
Möller, A., House, C., Wong, C. S. F., Scanlon, D. B., Liu, M. C. P., Ronai, Z. A., & Bowtell, D. D. L. (2008) · Oncogene · doi:10.1038/onc.2008.382 · Cited by 88
IFN‐β regulates CD73 and adenosine expression at the blood–brain barrier
Niemelä, J., Ifergan, I., Yegutkin, G. G., Jalkanen, S., Prat, A., & Airas, L. M. (2008) · European Journal of Immunology · doi:10.1002/eji.200838437 · Cited by 85
Airas, L. M., Niemelä, J., & Jalkanen, S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5411 · Cited by 84
CD73 Participates in Cellular Multiresistance Program and Protects against TRAIL-Induced Apoptosis
Mikhailov, A., Sokolovskaya, A., Yegutkin, G. G., Amdahl, H., West, A., Yagita∥, H., Lahesmaa, R., Thompson, L. F., Jalkanen, S., Блохин, Д. Ю., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.464 · Cited by 65
Richard, C. L., Tan, E. Y., & Blay, J. (2006) · International Journal of Cancer · doi:10.1002/ijc.22084 · Cited by 52
Stagg, J., Sharkey, J., Pommey, S., Young, R., Takeda, K., Yagita∥, H., Johnstone, R. W., & Smyth, M. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806849105 · Cited by 52
Self-citationGene expression profiling of tumor xenografts: In vivo analysis of organ‐specific metastasis
Lee, H.-R., Lin, E. C. K., Liu, L., & Smith, J. W. (2003) · International Journal of Cancer · doi:10.1002/ijc.11428 · Cited by 50
Hastie, C., Saxton, M. J., Akpan, A., Cramer, R., Masters, J. R., & Naaby‐Hansen, S. (2005) · Oncogene · doi:10.1038/sj.onc.1208747 · Cited by 49
Tan, E. Y., Mujoomdar, M., & Blay, J. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63299-3 · Cited by 41
Cited by
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Sharma, P., Hu-Lieskovan, S., Wargo, J. A., & Ribas, A. (2017) · Cell · doi:10.1016/j.cell.2017.01.017 · Cited by 5,588
“In addition, CD73 is the enzyme that dephosphorylates adenosine monophosphate (AMP) to form adenosine, thus also suppressing immune function and promoting tumor cell metastasis (Stagg et al., 2010), and also stimulates angiogenesis (Allard et al., 2014).”
Immune evasion in cancer: mechanistic basis and therapeutic strategies
Vinay, D. S., Ryan, E. P., Pawelec, G., Talib, W. H., Stagg, J., Elkord, E., Lichtor, T., Decker, W. K., Whelan, R. L., Kumara, H. M. C. S., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.004 · Cited by 1,625
Self-citationCD39 and CD73 in immunity and inflammation
Antonioli, L., Pacher, P., Vizi, E. S., & Haskó, G. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.03.005 · Cited by 1,263
Combination cancer immunotherapies tailored to the tumour microenvironment
Smyth, M. J., Ngiow, S. F., Ribas, A., & Teng, M. W. L. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.209 · Cited by 944
Self-citationThe ectonucleotidases CD 39 and CD 73: Novel checkpoint inhibitor targets
Allard, B., Longhi, M. S., Robson, S. C., & Stagg, J. (2017) · Immunological Reviews · doi:10.1111/imr.12528 · Cited by 927
Self-citation
Metadata
- Authors
- Stagg, J., Divisekera, U., McLaughlin, N., Sharkey, J., Pommey, S., Denoyer, D., Dwyer, K. M., & Smyth, M. J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2010-01-04
- Volume
- 107
- Issue
- 4
- Pages
- 1547-1552
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2062761137
- Cited by
- 572
- References
- 41
- FWCI
- 19.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.